🔎 Trials Near Me

Beranda › Kelebihan Berat Badan › Texas › Austin

Uji klinis Kelebihan Berat Badan di Austin, TX

18 studi untuk Kelebihan Berat Badan mencari peserta di lokasi sekitar Austin (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 2
  • Elligo Clinical Research Center /ID# 282166, Austin
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07752979

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Menerima pesertaFase 3
  • Texas Diabetes & Endocrinology, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Menerima pesertaFase 3
  • IMA Clinical Research Austin, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Menerima pesertaFase 3
  • Dell Children's Medical Center - PIN, Austin
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Menerima pesertaFase 3
  • IMA Clinical Research Austin, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Menerima pesertaFase 3
  • FutureSearch Trials of Neurology, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • Austin Heart, Austin
  • Velocity Clinical Research - Austin, Austin
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • IMA Clinical Research Austin, Austin
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

Menerima pesertaFase 2Sukarelawan sehat diterima
  • The University of Texas at Austin, Austin
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 3
  • AURORA-1 Clinical Site, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Menerima pesertaFase 3
  • AURORA-2 Clinical Site, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Austin
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • IMA Clinical Research Austin, Austin
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Menerima pesertaFase 3
  • Elligo Clinical Research Center, Austin
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Menerima pesertaFase 3
  • Elligo Clinical Research Center, Austin
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684144

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Menerima pesertaFase 3
  • ACCOMPLISH-1 Research Site, Austin
  • ACCOMPLISH-1 Research Site, Austin
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Menerima pesertaFase 1
  • Elligo Clin Res Centre, Austin
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT07607587

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Menerima pesertaFase 1
  • Corxel Investigational Site, Austin
Usia 18 hingga 55 · Wanita · Diperbarui 17 Jun 2026 · NCT07652047

Uji klinis Kelebihan Berat Badan di kota lain

Studi lain di Austin

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.